Doctor Vasileios Panoulas

Doctor Vasileios Panoulas

Royal Brompton and Harefield Hospital, Harefield, Uxbridge (United Kingdom of Great Britain & Northern Ireland)

Member of:

Dr Panoulas is an interventional cardiologist at Royal Brompton and Harefield Hospitals with special interest in CHIP PCI, cardiogenic shock management and structural interventions, in particular TAVI. He is also an honorary senior clinical lecturer at Imperial College. After graduating from the School of Medicine at the University of Ioannina, Greece, Dr Panoulas completed his PhD in the genetic regulation of hypertension in patients with rheumatoid arthritis. From 2008-10, he underwent his core medical training at Guys and St Thomas’ Hospital followed by cardiology core training at Hammersmith Hospital where he was appointed as a National Heart and Lung Institute academic clinical fellow (2010-13) and a NIHR Clinical Lecturer in 2014. He then undertook an interventional cardiology fellowship at San Raffaele Scientific Institute, Milan, Italy for a year (2013-14). He completed his MSc in interventional cardiology from Universita Vita-Salute San Raffaele, Milan, Italy.

Presentations

Mid-term outcomes in aortic stenosis patients treated with contemporary balloon expandable and self-expanding valves; does valve size have an impact on outcome?

Event: ESC Congress 2023

Topic: Aortic Valve Intervention

Session: TAVI outcomes: from pre-hospitalisation through valve choice and platelet reactivity

Access

Predictive value of residual SYNTAX score for clinical outcomes after High-Risk Percutaneous Coronary Intervention (HR-PCI): Evidence from pooled analysis of prospective studies

Event: ESC Congress 2023

Topic: Protected Percutaneous Coronary Intervention (PCI)

Session: Acute coronary syndromes and high-risk PCI: state of the art

Access

Impact of early (<24h) versus delayed (>24h) intervention in patients with non ST segment elevation myocardial infarction (an observational study of 20882 patients)

Event: ESC Congress 2020

Topic: Outcome

Session: Prognostic Impact of Percutaneous Coronary Interventions

Access

CABG confers long-term survival benefit over PCI with second generation stents in real-world patients with multi-vessel coronary artery disease: a propensity matched study of 2698 patients

Event: ESC Congress 2018

Topic: Coronary Arteries

Session: Advances in coronary surgery

Access

Increased survival of females with severe aortic stenosis after transcatheter aortic valve implantation compared to surgical aortic valve replacement; a meta-analysis of randomised controlled studies

Event: ESC Congress 2016

Topic: Percutaneous / endovascular treatment

Session: Percutaneous structural heart interventions

Access

Doctor Vasileios Panoulas

Biography

Contributor content

Mid-term outcomes in aortic stenosis patients treated with contemporary balloon expandable and self-expanding valves; does valve size have an impact on outcome?

Predictive value of residual SYNTAX score for clinical outcomes after High-Risk Percutaneous Coronary Intervention (HR-PCI): Evidence from pooled analysis of prospective studies

Impact of early (<24h) versus delayed (>24h) intervention in patients with non ST segment elevation myocardial infarction (an observational study of 20882 patients)

CABG confers long-term survival benefit over PCI with second generation stents in real-world patients with multi-vessel coronary artery disease: a propensity matched study of 2698 patients

Increased survival of females with severe aortic stenosis after transcatheter aortic valve implantation compared to surgical aortic valve replacement; a meta-analysis of randomised controlled studies

ESC 365 is supported by